The Quality Digest
March 2023 EditionMarch 2, 2023
Safety and Patient Experience with At-Home Infusion of Ocrelizumab for Multiple Sclerosis
Amerita Specialty Infusion Services’ clinical leaders Lou Anne Epperson and Ashley Banks were among the authors on this recent study of safety and patient satisfaction with at-home infusion of ocrelizumab for MS, published in the Annals of Clinical and Translational Neurology.
Clinical Advisory: CDC Advises to Stop Use of EzriCare Artificial Tears Lubricant Eye Drops
The CDC urges halting use of EzriCare Artificial Tears Lubricant Eye Drops pending investigation into multi-state infection outbreaks causing permanent vision loss, hospitalization, and one death.
Clinical Alert: Omicron Subvariants Predominance Leads to EVUSHELD Halt
The FDA has updated the EUA for EVUSHELD and rescinded the authorization for use as pre-exposure prophylaxis of COVID-19 in every US region as it is not expected to neutralize numerous Omicron subvariants. There are currently no COVID-19 monoclonal antibodies authorized for any use.
JAYPIRCA™ and ORSERDU™ Now Available from Onco360
JAYPIRCA™ (pirtobrutinib) and ORSERDU™ (elacestrant) are now available from Onco360 for the treatment of relapsed or refractory mantle cell lymphoma and for some types of ER-positive metastatic breast cancer, respectively.
Monthly Minute: Tapering Medications
Check out this month’s “Monthly Minute,” developed by our Consultant Pharmacists, on pharmacy-related topics important to resident care.
All webinar times are 1:00pm ET / 12:00pm CT
Tuesday, March 7: Insulin Management
Tuesday, March 14: Talking Shop: Improving CNA-Nurse Communications in Long-Term Care
Tuesday, March 28: Drug Pricing Reform in Motion: What You Need to Know Now
CMS plans to increase psychotropic drug oversight to include targeted audits. Listen to our latest “Spoonful of Sugar” podcast as hosts TJ Griffin and John O’Connor discuss the importance of implementing a psychotropic stewardship program to prevent headaches, problems, and costs down the line – and get a leg up if CMS decides to mandate such an initiative.